Past Event

Health Care Reform: Implementing Comparative Effectiveness Research

The American Recovery and Reinvestment Act of 2009 invested $1.1 billion in federal initiatives to begin the important and necessary work of comparative effectiveness research (CER), a key building block in health care reform. However, whether CER can fulfill expectations of better quality, outcomes and value in health care will depend on how it is implemented.

A forum hosted by the Engelberg Center for Health Care Reform and The Hamilton Project addressed many of the key questions surrounding CER and featured remarks from Sen. Max Baucus (D-Mont.) and Office of Management and Budget Director Peter Orszag. Three discussion papers released at the event focus on how research questions should be prioritized, what methods and data infrastructure are needed for CER, and how CER findings can be used to improve clinical and health policy decisions. A series of distinguished panels discussed the papers’ findings.

Participants took questions after each panel.

Watch the archived webcast »
 
Download discussion papers »

Agenda

Getting Our Money's Worth from Patient-Centered Health Research

Comparative Effectiveness Research: What It Is, What It's Not and Why We Need More

P

David Lansky

President and CEO, Pacific Business Group on Health

Welcome

The Future of Comparative Effectiveness Research in the United States

Introductory Remarks

Setting Priorities for Comparative Effectiveness Research (Discussion Paper 1)

P

Harold Sox

Past President, American College of Physicians

Strategies to Improve Comparative Effectiveness Research Methods and Data Infrastructure (Discussion Paper 2)

V

Joshua Ofman

Vice President of Global Coverage & Reimbursement and Global Health Economics, Amgen

C

Ellen Sigal

Chairperson and Founder - Friends of Cancer Research

From Better Evidence to Better Care: Using Comparative Effectiveness Research to Guide Practice and Policy (Discussion Paper 3)

V

Marc Berger

Vice President, Global Health Outcomes, Eli Lilly & Co.

E

Sam Nussbaum

Executive Vice President, Clinical Health Policy and Chief Medical Officer - WellPoint, Inc.

Closing Remarks

More Information

Contact
(202) 797-6105
Get a weekly events calendar from Brookings

More